Monascus Garlic Fermented Extract, a unique fermented material, reduces the development of hyperlipidemia and atherosclerotic lesions in cholesterol-fed rabbits

Pharmacometrics

Volumn 65, Issue 3-4, 2003, Pages 51-59

  Sumioka, Isao ^a   Yasuda, Kayo ^a   Kashimoto, Naoki ^a   Ushijima, Mitsuyasu ^a   Moriguchi, Toru ^a   Kyo, Eikai ^a  

^a WAKUNAGA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Atherosclerosis; Cholesterol; Garlic; Monascus pilosus; Rabbit; Triglyceride

Indexed keywords

CHOLESTEROL; GARLIC EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; EAR ARTERY; FERMENTATION; FUNGUS; GARLIC; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; MONASCUS PILOSUS; NONHUMAN; RABBIT;

EID: 0242543263     PISSN: 03008533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Anitschkow, N.D. (1913): Uber die veranderungen der kanin-chenaorta bei experimenteller cholesterinsteatase, Beitr. Pathol. Anat., 56, 379-404.
2. Aniya, Y., Ohtani, I., Higa, T., Miyagi, C., Gibo, H., Shimabukuro, M., Nakanishi, H. and Taira, J. (2000): Dimerumic acid as an antioxidant of the mold, Monascus anka, Free Radic. Biol. Med., 28, 999-1004.
3. Arad, Y., Ramakrishnan, R. and Ginsberg, H.N. (1992): Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: Evidence for reduced assembly and secretion of triglyceride-rich lipoproteins, Metabolism, 41, 487-493.
4. Assmann, G., Schulte, H., von Eckardstein, A. and Huang, Y. (1996): High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport, Atherosclerosis, 124(Suppl.), S11-S20.
5. Austin, M.A., Hokanson, J.E. and Edwards, K.L. (1998): Hypertriglyceridemia as a cardiovascular risk factor, Am. J. Cardiol., 81, 7B-12B.
6. Bersot, T.P., Innerarity, T.L., Mahley, R.W. and Havel, R.J. (1983): Cholesteryl ester accumulation in mouse peritoneal macrophages induced by β-migrating very low density lipoproteins from patients with atypical dysbetalipoproteinemia, J. Clin. Invest., 72, 1024-1033.
7. Brattsand, R. (1976): Distribution of cholesterol and triglycerides among lipoprotein fractions in fat-fed rabbits at different levels of serum cholesterol, Atherosclerosis, 23, 97-110.
8. Brown, M.S. and Goldstein, J.L. (1983): Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis, Annu. Rev. Biochem., 52, 223-261.
9. Cambien, F., Jacqueson, A., Richard, J.L., Warnet, J.M., Ducimetiere, P. and Claude, J.R. (1986): Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study, Am. J. Epidemiol., 124, 624-632.
10. Castelli, W.P., Garrison, R.J., Wilson, P.W.F., Abbott, R.D., Kalousdian, S. and Kannel, W.B. (1986): Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study, JAMA, 256, 2835-2838.
11. Folch, J., Lees, M. and Sloane Stanley, G.H. (1957): A simple method for the isolation and purification of total lipides from animal tissues, J. Biol Chem., 226, 497-509.
12. Grundy, S.M. (1988): HMG-CoA reductase inhibitors for treatment of hypercholesterolemia, N. Engl. J. Med., 319, 24-33.
13. Hamsten, A., Faire, U., Walldius, G., Dahlén, G., Szamosi, A., Landou, C., Blombäck, M. and Wiman, B. (1987): Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction, Lancet, 2, 3-9.
14. Iso, H., Naito, Y., Sato, S., Kitamura, A., Okamura, T., Sankai, T., Shimamoto, T., Iida, M. and Komachi, Y. (2001): Serum triglycerides and risk of coronary heart disease among Japanese men and women, Am. J. Epidemiol., 153, 490-499.
15. Itabe, H., Takeshima, E., Iwasaki, H., Kimura, J., Yoshida, Y., Imanaka, T. and Takano, T. (1994): A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides, J. Biol Chem., 269, 15274-15279.
16. Jeppesen, J., Hein, H.O., Suadicani, P. and Gyntelberg, F. (1998): Triglyceride concentration and ischemic heart disease. An eight-year follow-up in the Copenhagen Male Study, Circulation, 97, 1029-1036.
17. Kita, T., Nagano, Y., Yokode, M., Ishii, K., Kume, N., Ooshima, A., Yoshida, H. and Kawai, C. (1987): Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia, Proc. Natl. Acad. Sci. USA, 84, 5928-5931.
18. Koga, T., Shimada, Y., Kuroda, M., Tsujita, Y., Hasegawa, K. and Yamazaki, M. (1990): Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, Biochim. Biophys. Acta., 1045, 115-120.
19. Mahley, R.W., Innerarity, T.L., Brown, M.S., Ho, Y.K. and Goldstein, J.L. (1980): Cholesteryl ester synthesis in macrophages:stimulation by β-very low density lipoproteins from cholesterol-fed animals of several species, J. Lipid Res., 21, 970-980.
20. Nielsen, L.B., Stender, S. and Kjeldsen, K. (1993) Effect of lovastatin on cholesterol absorption in cholesterol-fed rabbits, Pharmacol. Toxicol., 72, 148-151.
21. Oseroff, A., Krishnamurti, C., Hassett, A., Tang, D. and Alving, B. (1989): Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease, J. Lab. Clin. Med., 113, 88-93.
22. Puhl, H., Waeg, G. and Esterbauer, H. (1994): Methods to determine oxidation of low-density lipoproteins, Mehods Enzymol., 233, 425-441.
23. Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., Macfarlane, P.W., McKillop, J.H. and Packard, C.J. (1995): Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia, N. Engl. J. Med., 333, 1301-1307.
24. Slater, E.E. and MacDonald, J.S. (1988): Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative, Drugs, 36(Suppl. 3), 72-82.
25. Stamler, J., Wentworth, D. and Neaton, J.D. (1986): Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT), JAMA, 256, 2823-2828.
26. Sviridov, D. and Nestel, P. (2002): Dynamics of reverse cholesterol transport: protection against atherosclerosis, Atherosclerosis, 161, 245-254.
27. Taira, J., Miyagi, C. and Aniya, Y. (2002): Dimerumic acid as an antioxidant from the mold, Monascus anka:the inhibition mechanisms against lipid peroxidation and heme-protein-mediated oxidation, Biochem. Pharmacol., 63, 1019-1026.
28. Williams, R.J., Motteram, J.M., Sharp,. C.H. and Gallagher, P.J. (1992): Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits, Atherosclerosis, 94, 153-159.
29. Witztum, J.L. and Steinberg, D. (1991): Role of oxidized low density lipoprotein in atherogenesis, J. Clin. Invest., 88, 1785-1792.
30. Yano, Y., Irie, N., Homma, Y., Tsushima, M., Takeuchi, I., Nakaya, N. and Goto, Y. (1980): High density lipoprotein cholesterol levels in the Japanese, Atherosclerosis, 36, 173-181.
31. Ylä-Herttuala, S., Palinski, W., Rosenfeld, M.E., Parthasarathy, S., Carew, T.E., Butler, S., Witztum, J.L. and Steinberg, D. (1989): Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man, J. Clin. Invest., 84, 1086-1095.
32. Zak, B. (1957): Simple rapid microtechnic for serum total cholesterol, Am. J. Clin. Pathol., 27, 583-588.
33. Zhang, A., Vertommen, J., Van Gaal, L. and De Leeuw, I. (1994): A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation, Clin. Chim. Acta., 227, 159-173.